2025-11-30 - Analysis Report
Here's a comprehensive analysis of Procter & Gamble (PG) based on the provided data:

**0) Report in English: Simple Numbers and Analysis**

**1) Return Rate Comparison:**

*   **Ticker:** PG (Procter & Gamble Co) - A multinational consumer goods corporation that manufactures and markets a wide range of products.
*   **PG Cumulative Return:** 29.58%
*   **S&P 500 (VOO) Cumulative Return:** 101.92%
*   **Divergence:** -62.6 (Relative Divergence: 11.5)
*   **Analysis:** PG has significantly underperformed the S&P 500 over the analyzed period. The divergence of -62.6 indicates a substantial difference in cumulative returns. The relative divergence of 11.5 suggests that the current divergence is near the lower end of its historical range, implying the underperformance is significant compared to its own historical patterns.

**Alpha, Beta, and Performance Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 21.0% | 7.9% | -8.0% | 0.0 | 215.0 |
| 2016-2018  | 9.0% | 67.3% | -6.0% | 0.1 | 215.1 |
| 2017-2019  | 24.0% | 70.4% | 2.0% | 0.3 | 292.3 |
| 2018-2020  | 27.0% | 78.8% | 4.0% | 0.4 | 325.7 |
| 2019-2021  | 41.0% | 78.8% | -5.0% | 0.5 | 382.9 |
| 2020-2022  | 13.0% | 79.4% | 13.0% | 0.6 | 354.7 |
| 2021-2023  | 26.0% | 79.4% | 24.0% | 0.4 | 343.0 |
| 2022-2024  | 9.0% | 79.4% | -12.0% | 0.4 | 392.4 |
| 2023-2025  | -14.0% | 80.1% | -81.0% | 0.2 | 346.8 |

*   **CAGR:** The Compound Annual Growth Rate shows varying performance across the periods. The recent negative CAGR indicates a decline in performance.
*   **MDD:** The Maximum Drawdown is consistently high, suggesting significant potential for loss during these periods.
*   **Alpha:**  Alpha measures the stock's performance relative to a benchmark, considering risk. A negative Alpha indicates underperformance relative to the benchmark, while a positive Alpha indicates outperformance. The recent Alpha of -81% is concerning.
*   **Beta:** Beta measures the stock's volatility relative to the market. A Beta close to 0 indicates low volatility.
*   **Cap(B):** Market Capitalization is presented in Billions.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** $148.16
*   **Previous Close:** $148.25
*   **Change:** -$0.06
*   **5-day SMA:** 148.56
*   **20-day SMA:** 147.60
*   **60-day SMA:** 151.33
*   **Analysis:** The current price is slightly below the 5-day SMA and 60-day SMA but above the 20-day SMA. This mixed signal suggests a period of consolidation or potential short-term upward movement, but the 60-day SMA resistance could present a challenge. The very small change from the previous close indicates relatively stable recent trading.

**3) RSI, PPO, and Investment Indicators:**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 53.26 (Neutral, neither overbought nor oversold)
*   **PPO:** 0.20 (Slightly positive, indicating a potential upward trend)
*   **Hybrid Signal:** Cash 0% / Buy 100% (Very Safe - MRI:0.90)
*   **Recent Relative Divergence Change (20 days):** 6.8% (Short-term increase)
*   **Expected Return:** 9.0% (Long-term expectation compared to S&P 500)
*   **Analysis:** Despite the high MRI suggesting investment, the RSI indicates a neutral condition. The PPO suggests a possible uptrend. The Hybrid Signal recommends a full investment strategy, possibly driven by the high MRI. The short-term increase in relative divergence and positive expected return suggest potential for future gains.

**4) Recent News & Significant Events (Yahoo Finance):**

*   **[2025-11-29]** Procter & Gamble Stock (PG) Opinions on Q1 FY26 Earnings and Price Decline (Quiver Quantitative): *Focuses on recent earnings and potential price movement.*
*   **[2025-11-24]** Procter & Gamble: Nothing Not To Like After 4 Years Sideways (Rating Upgrade) (Seeking Alpha): *Suggests a positive outlook after a period of stagnation.*
*   **[2025-11-30]** BLI Banque de Luxembourg Investments Buys 46,700 Shares of Procter & Gamble Company (The) $PG (MarketBeat): *Indicates institutional investor confidence.*
*   **[2025-11-06]** Jim Cramer on Procter & Gamble: “If I Wanted to Start a Position, I Would Wait” (Yahoo Finance): *Suggests caution from a prominent market commentator.*
*   **[2025-10-30]** My Top Value Stock to Buy for 2026 (and It's Not Even Close) (The Motley Fool): *Highlights PG as a potential value investment for the long term.*
*   **[2025-11-18]** Why Procter & Gamble Stock (PG) is Primed for a Wake-Up Call (TipRanks): *Indicates a potential catalyst for future growth.*
*   **Analysis:** The news articles present a mixed picture. Some suggest a positive outlook and potential for growth (rating upgrade, institutional buying, value stock), while others advise caution (Cramer) or point to recent challenges (earnings, price decline). This indicates a degree of uncertainty surrounding PG's immediate future.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 2.00)
*   **Opinions:** 22
*   **Target Price:** Avg: $169.05 / High: $186.00 / Low: $148.00
*   **Analysis:**  Analysts generally have a "Buy" rating on PG, with a significant average target price above the current price. This suggests an expectation of future price appreciation. The low target price is similar to the current price.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-10-24 | 2    | 22.39 B$  |
| 2025-04-24 | 1.58 | 19.78 B$  |
| 2025-01-22 | 1.94 | 21.88 B$  |
| 2024-10-18 | 1.65 | 21.74 B$  |
| 2025-10-24 | 1.65 | 21.74 B$  |

*   **Analysis:** Revenue figures show some fluctuation. EPS has been increasing and has been above $1.50 for the last five quarters, showing consistency.

**6) Financial Information: Revenue, Profitability, Capital, and ROE**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $22.39B  | 51.37%        |
| 2025-06-30   | $20.89B  | 49.11%        |
| 2025-03-31   | $19.78B  | 50.98%        |
| 2024-12-31   | $21.88B  | 52.39%        |
| 2024-09-30   | $21.74B  | 52.06%        |

*   **Analysis:** Revenue demonstrates variability across the quarters, with the highest being in the most recent quarter. Profit margins remain consistently high, indicating strong profitability.

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-09-30   | $53.27B  | 8.92%   |
| 2025-06-30   | $52.01B  | 6.95%   |
| 2025-03-31   | $52.27B  | 7.21%   |
| 2024-12-31   | $51.17B  | 9.05%   |
| 2024-09-30   | $51.84B  | 7.64%   |

*   **Analysis:** Equity has been steadily increasing. ROE (Return on Equity) has been fluctuating, indicating variability in the company's efficiency in generating profits from shareholders' equity.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** PG has significantly underperformed the S&P 500 over the analyzed period.
*   **Mixed Signals:**  Technical indicators, analyst opinions, and recent news present a mixed picture, with both positive and cautionary signals.
*   **Financial Strength:**  PG demonstrates strong and consistent profit margins and a growing equity base, indicating financial health.
*   **Growth Potential:**  Despite recent underperformance, the positive expected return, recent divergence change, and analyst target prices suggest potential for future gains.
*   **Investment Recommendation:** Considering the high MRI, analyst buy ratings, and potential for growth, a cautious investment approach may be warranted. However, the significant underperformance relative to the S&P 500 and mixed signals from news and technical indicators suggest further due diligence is crucial. Investors should weigh the company's financial strength and potential upside against the risks and recent underperformance.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.